Detalles de la búsqueda
1.
Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention.
BMC Cardiovasc Disord;
21(1): 106, 2021 02 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33607967
2.
Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario.
Circulation;
140(21): 1706-1716, 2019 11 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31630535
3.
Impact of routine right parasternal electrocardiographic screening in assessing eligibility for subcutaneous implantable cardioverter-defibrillator.
J Cardiovasc Electrophysiol;
31(1): 103-111, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31724763
4.
Clinical outcomes after primary prevention defibrillator implantation are better predicted when the left ventricular ejection fraction is assessed by cardiovascular magnetic resonance.
J Cardiovasc Magn Reson;
22(1): 48, 2020 06 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32580786
5.
Intermuscular S-ICD Implantation in Pediatric Patients.
Thorac Cardiovasc Surg;
68(1): 68-71, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31630382
6.
Effectiveness of single- vs dual-coil implantable defibrillator leads: An observational analysis from the SIMPLE study.
J Cardiovasc Electrophysiol;
30(7): 1078-1085, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30945798
7.
Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.
J Cardiovasc Electrophysiol;
30(9): 1626-1635, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31165517
8.
Association of cardiovascular magnetic resonance-derived circumferential strain parameters with the risk of ventricular arrhythmia and all-cause mortality in patients with prior myocardial infarction and primary prevention implantable cardioverter defibrillator.
J Cardiovasc Magn Reson;
21(1): 28, 2019 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31096987
9.
Incidence of appropriate implantable cardioverter-defibrillator therapy and mortality after implantable cardioverter-defibrillator generator replacement: results from a real-world nationwide cohort.
Europace;
21(8): 1211-1219, 2019 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31329849
10.
Primary prevention with the implantable cardioverter-defibrillator in high-risk long-QT syndrome patients.
Europace;
21(2): 339-346, 2019 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29947754
11.
Clinical outcome in patients with implantable cardioverter-defibrillator and cancer: a nationwide study.
Europace;
21(3): 465-474, 2019 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30535192
12.
Risk of subsequent ventricular arrhythmia is higher in primary prevention patients with implantable cardioverter defibrillator than in secondary prevention patients.
BMC Cardiovasc Disord;
19(1): 230, 2019 10 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31638918
13.
Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure.
Circulation;
136(19): 1772-1780, 2017 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28877914
14.
Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of prospective randomized clinical trials.
Europace;
20(FI2): f211-f216, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29161424
15.
Optimal method of measuring the T-peak to T-end interval for risk stratification in primary prevention.
Europace;
20(4): 698-705, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28339886
16.
Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death.
Europace;
20(1): 65-72, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28082419
17.
Management of patients with ventricular arrhythmias and prevention of sudden cardiac death-translating guidelines into practice: results of the European Heart Rhythm Association survey.
Europace;
20(FI2): f249-f253, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29878156
18.
Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study.
Europace;
20(FI2): f217-f224, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29684191
19.
A decision support tool to inform local suicide prevention activity in Greater Western Sydney (Australia).
Aust N Z J Psychiatry;
52(10): 983-993, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29671335
20.
Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
J Cardiovasc Electrophysiol;
28(6): 659-665, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28316104